Information Provided By:
Fly News Breaks for January 24, 2020
CCXI
Jan 24, 2020 | 07:07 EDT
H.C. Wainwright analyst Edward White raised his price target for ChemoCentryx to $60 from $40 and keeps a Buy rating on the shares. The analyst sees several potential catalysts in 2020.
News For CCXI From the Last 2 Days
There are no results for your query CCXI